NEW YORK (GenomeWeb News) – Gamma-Dynacare Medical Laboratories announced today the completion of its acquisition of a controlling interest in Impact Genetics.
Terms of the purchase were not disclosed.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Nature this week: weighting scheme increases GWAS power, and more.
Marc Tessier-Lavigne is to be the next president of Stanford University.
Walgreens has given Theranos 30 days to fix its lab issues, the Wall Street Journal reports.
Journals and research funding agencies pledge to enable the sharing of Zika virus research.
This webinar will discuss the use of a hybrid capture-based FFPE DNA sequencing methodology with the potential for advancing precision oncology studies.